WVU020925: A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients with CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
- Title
- A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients with CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
- Principal Investigator
- Emadi, Ashkan
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Leukemia
- Multiple Myeloma
- Other Hematopoietic
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts